Received Feb 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Z011972 | — |
No additional AE; The patient received 3 doses of VAQTA previously.; Temperature excursion; This Spontaneous report was received from Consumer or other non-health professional and referred to a 2-year-old Female patient. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication. On an unknown date, a temperature excursion was performed (Product storage error). On 09-Jan-2026, patient was vaccinated with hepatitis a vaccine, inactivated, pediatric, 25 u/0.5ml suspension for injection (VAQTA) lot number Z011972 expiration date not reported, but upon internal validation established as 13-Oct-2027 for prophylaxis (dose, route of administration, anatomical location, lot number and expiration date were not reported). The patient received 3 doses of patient was vaccinated with hepatitis a vaccine, inactivated, pediatric, 25 u/0.5ml suspension for injection (VAQTA) previously (Extra dose administered). The 4th dose of hepatitis a vaccine, inactivated, pediatric, 25 u/0.5ml suspension for injection (VAQTA) was refused for unknown reason. No additional adverse event.